113 related articles for article (PubMed ID: 38847248)
1. Development and Evaluation of PEG-Gelatin-Based Microparticles to Enhance the Oral Delivery of Insulin.
Alfa J; Ben A; Buxaderas E; Akpa P; Hanifah A; Oseni OM; Kenechukwu FC; Momoh MA; Diaz DD
Curr Pharm Des; 2024 Jun; ():. PubMed ID: 38847248
[TBL] [Abstract][Full Text] [Related]
2. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
4. Preparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol): characterization and application to entrapment into biodegradable microspheres.
Morita T; Horikiri Y; Suzuki T; Yoshino H
Int J Pharm; 2001 May; 219(1-2):127-37. PubMed ID: 11337173
[TBL] [Abstract][Full Text] [Related]
5. Development of PLGA-PEG-COOH and gelatin-based microparticles dual delivery system and E-beam sterilization effects for controlled release of BMP-2 and IGF-1.
Bai Y; Moeinzadeh S; Kim S; Park Y; Lui E; Tan H; Zhao W; Zhou X; Yang YP
Part Part Syst Charact; 2020 Oct; 37(10):. PubMed ID: 33384477
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application.
Wang J; Li S; Chen T; Xian W; Zhang H; Wu L; Zhu W; Zeng Q
J Mater Sci Mater Med; 2019 Aug; 30(8):93. PubMed ID: 31392433
[TBL] [Abstract][Full Text] [Related]
7. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
8. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Yeh MK
J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421
[TBL] [Abstract][Full Text] [Related]
9. Surface-modified mucoadhesive microparticles as a controlled release system for oral delivery of insulin.
Mumuni MA; Kenechukwu FC; Ernest OC; Oluseun AM; Abdulmumin B; Youngson DC; Kenneth OC; Anthony AA
Heliyon; 2019 Sep; 5(9):e02366. PubMed ID: 31535040
[TBL] [Abstract][Full Text] [Related]
10. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
[TBL] [Abstract][Full Text] [Related]
11. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
Morishita M; Goto T; Nakamura K; Lowman AM; Takayama K; Peppas NA
J Control Release; 2006 Feb; 110(3):587-94. PubMed ID: 16325951
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
13. Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery.
D'Souza B; Bhowmik T; Uddin MN; Oettinger C; D'Souza M
Drug Dev Ind Pharm; 2015; 41(8):1288-93. PubMed ID: 25156483
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin delivery.
Yang Y; Liu Y; Chen S; Cheong KL; Teng B
Carbohydr Polym; 2020 Oct; 246():116617. PubMed ID: 32747257
[TBL] [Abstract][Full Text] [Related]
15. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2003 Sep; 91(3):299-313. PubMed ID: 12932709
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model.
Tomar L; Tyagi C; Kumar M; Kumar P; Singh H; Choonara YE; Pillay V
Int J Nanomedicine; 2013; 8():505-20. PubMed ID: 23429428
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG.
Haggag Y; Abdel-Wahab Y; Ojo O; Osman M; El-Gizawy S; El-Tanani M; Faheem A; McCarron P
Int J Pharm; 2016 Feb; 499(1-2):236-246. PubMed ID: 26746800
[TBL] [Abstract][Full Text] [Related]
19. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2005 Jan; 101(1-3):111-25. PubMed ID: 15588898
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of polysaccharides-based hydrogel microparticles as oral insulin delivery in streptozotocin-induced type 2 diabetic mice.
Yang Y; Chen S; Liu Y; Huang Y; Cheong KL; Teng B; Liu W
Biomed Pharmacother; 2021 Jan; 133():110941. PubMed ID: 33232923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
